Valbiotis
Develops clinically proven, plant-based supplements for metabolic diseases.
ALVAL | PA
Overview
Corporate Details
- ISIN(s):
- FR0013254851
- LEI:
- 969500VP4JBJCF0MOP60
- Country:
- France
- Address:
- RUE PAUL VATINE, 17180 PERIGNY
- Website:
- https://www.valbiotis.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other food products
Description
Valbiotis is a research and development company that develops and commercializes plant-based dietary supplements for the prevention and management of metabolic diseases. The company's portfolio is centered on its patented "TOTUM" line of active substances, which undergo rigorous clinical trials to validate their efficacy. Key products include TOTUM•63 for reducing blood glucose in prediabetic individuals, TOTUM•448 for cardio-liver health, and TOTUM•854 for managing blood pressure. Valbiotis provides scientifically proven, natural, non-drug solutions and is transitioning from a research-focused model to a commercial-stage enterprise.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-26 17:40 |
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue …
|
English | 470.3 KB | ||
| 2025-06-26 17:40 |
VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9…
|
French | 419.2 KB | ||
| 2025-06-26 17:40 |
VALBIOTIS SA: Valbiotis announces the success of its 6.9 million rights issue e…
|
English | 142.5 KB | ||
| 2025-06-06 08:00 |
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 579.9 KB | ||
| 2025-06-06 08:00 |
VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec…
|
French | 511.1 KB | ||
| 2025-06-06 08:00 |
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 305.6 KB | ||
| 2025-06-02 22:48 |
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 131.2 KB | ||
| 2025-06-02 22:48 |
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.1 KB | ||
| 2025-05-22 17:40 |
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
|
English | 235.0 KB | ||
| 2025-05-22 17:40 |
VALBIOTIS SA: Valbiotis commercialisera le 2 juin prochain sa solution Valbio…
|
French | 201.0 KB | ||
| 2025-05-22 17:40 |
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO Cardio-circulation on 2 June
|
English | 27.2 KB | ||
| 2025-05-14 17:08 |
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 131.7 KB | ||
| 2025-05-14 17:08 |
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 17.6 KB | ||
| 2025-05-06 17:40 |
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expan…
|
English | 350.0 KB | ||
| 2025-05-06 17:40 |
VALBIOTIS SA: Extension du maillage commercial, lancements de produits, montée …
|
French | 238.8 KB |
Automate Your Workflow. Get a real-time feed of all Valbiotis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valbiotis
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valbiotis via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | N/A | Other | Other | 10,400 | 46,072.00 EUR |
Peer Companies
